Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Omkar Pharmachem Ltd (NSE: OMKARPH), ISIN INE501C01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
OMKARPH last traded at ₹8.70 (+4.95%), with a 52-week range of ₹9.95 to ₹29.74 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 0.03%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 12/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.